Published Medical Nav1.7 Inhibitor Pharmacological inhibition of Nav1.7 is a promising therapeutic strategy for the treatment of some pain disorders caused by mutations of SCN9A, the gene encoding Nav1.7 By The University of Queensland
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
